Bolivia (Plurinational State of) vs Burkina Faso: Proportion of the target population who received
Bolivia (Plurinational State of)
61.0%
in 2024
Burkina Faso
65.0%
in 2024
Bolivia (Plurinational State of) rank
166th
Burkina Faso rank
163rd
Proportion of the target population who received over time
- Bolivia (Plurinational State of)
- Burkina Faso
How they compare
Burkina Faso currently reports 65.0% against 61.0% in Bolivia (Plurinational State of), a difference of 4.0%.
That makes Burkina Faso's figure about 1.1 times Bolivia (Plurinational State of)'s.
Across all 7 years both countries report, Burkina Faso has been ahead every year.
Bolivia (Plurinational State of) ranks 166th and Burkina Faso ranks 163rd of 193 countries.
Burkina Faso has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bolivia (Plurinational State of) | Burkina Faso | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 41.0% | 71.0% | 30.0% | Burkina Faso |
| 2020s | 52.4% | 67.6% | 15.2% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Bolivia (Plurinational State of) or Burkina Faso?
- Burkina Faso, at 65.0% against 61.0% in Bolivia (Plurinational State of) as of 2024.
- What is the difference in proportion of the target population who received between Bolivia (Plurinational State of) and Burkina Faso?
- 4.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Bolivia (Plurinational State of) and Burkina Faso?
- 7 years are reported by both, from 2018 to 2024.
- How do Bolivia (Plurinational State of) and Burkina Faso rank globally for proportion of the target population who received?
- Bolivia (Plurinational State of) ranks 166th and Burkina Faso ranks 163rd of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.